Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Trends and Finance: Page 2
Co-Diagnostics opens manufacturing facility in Utah
By
LabPulse.com staff writers
Molecular diagnostics firm Co-Diagnostics has opened a new manufacturing facility in South Salt Lake, UT, holding a ribbon-cutting event to inaugurate the facility on April 11.
April 16, 2024
OraSure discloses cybersecurity breach
By
LabPulse.com staff writers
OraSure Technology disclosed a cybersecurity incident involving data theft that occurred in late March.
April 15, 2024
Seaport Therapeutics launches with $100M financing round
By
LabPulse.com staff writers
Clinical-stage biopharmaceutical company Seaport Therapeutics launched with the announcement of the closing of a $100 million oversubscribed series A financing round.
April 9, 2024
Johnson & Johnson to acquire Shockwave Medical
By
LabPulse.com staff writers
Johnson & Johnson will acquire Shockwave Medical, expanding Johnson & Johnson MedTech's position in the growing medtech market for cardiovascular intervention.
April 8, 2024
Binx Health closes $65M financing round
By
LabPulse.com staff writers
Binx Health announced that it successfully closed a $65 million series F financing round.
April 5, 2024
Biofidelity completes $24M financing round
By
LabPulse.com staff writers
Genomics company Biofidelity announced that it has completed a financing round totaling $24 million, bringing the firm’s total funding since its founding in 2019 to $60 million.
April 3, 2024
Magritek enhances benchtop NMR instruments
By
LabPulse.com staff writers
Nuclear magnetic resonance software builds capabilities for labs looking for synthetic drugs and new psychoactive substances, using benchtop NMR instruments.
March 29, 2024
Florida man pleads guilty in $4.6 million kickback scheme
By
LabPulse.com staff writers
A Tampa, FL man pleaded guilty for his role in a scheme to receive kickbacks and bribes from labs in exchange for referrals of patient DNA samples and genetic tests, according to the U.S. Attorney's Office for the District of New Jersey.
March 29, 2024
Labcorp acquires BioReference Health assets
By
LabPulse.com staff writers
Labcorp and Opko Health subsidiary BioReference Health have announced that they have made an agreement for Labcorp to acquire certain of BioReference Health’s assets.
March 28, 2024
AbbVie to buy Landos Biopharma for up to $212M
By
LabPulse.com staff writers
AbbVie has announced that it will buy drug developer Landos Biopharma in a deal worth up to $212 million. The deal will expand Abbvie’s portfolio, especially in the arena of immune system-related illnesses.
March 25, 2024
Protein design firm Profluent raises $35M in funding
By
LabPulse.com staff writers
Protein design firm Profluent has raised $35 million in funding, bringing the total funding raised by the company to $44 million.
March 25, 2024
Bluebird Bio secures up to $175M in debt financing
By
LabPulse.com staff writers
Bluebird Bio has secured up to $175 million in debt financing with Hercules Capital, having entered into a five-year term loan facility that provides funds in separate tranches.
March 18, 2024
Previous Page
Page 2 of 133
Next Page